The Evolving Context of Driver Mutations:ROS1Rearrangement in Metastatic Non-Small Cell Lung Cancer

    loading  Checking for direct PDF access through Ovid


The discovery of driver mutations in non-small cell lung cancer (NSCLC) has led to the advent of targeted therapy and changed the clinical landscape. ROS1 is a rare driver mutation found in 1%-2% of patients diagnosed with NSCLC. This case highlights a young woman of Asian descent with no history of smoking diagnosed with NSCLC and ROS1 rearrangement and discusses the implications for oncology nurses in clinical practice.

Related Topics

    loading  Loading Related Articles